Consistent efficacy and safety of erenumab over time in patients with episodic migraine who completed a 5-year, open-label extension study (2328)
Neurology | December 7, 2023 | Volume: 96 | Issue: 15_supplement | Pages: No page available
10.1212/wnl.96.15_supplement.2328